BREATHWISE: an AI-based early warning for COPD flare-ups
Official title: BREATHWISE - An AI-Driven Early Warning System for COPD Exacerbations
Funded at Lynntech, INC. · NIH-11409774 · Data updated 2026-11-12
A personalized AI-powered system using wearables and phones to spot signals that a COPD flare-up may be coming so patients and clinicians can intervene earlier.
Quick facts
| Grant type | Sbir 1 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Lynntech, INC. NIH-funded |
| Lab location | 1 site (College Station, United States) |
| Project start | September 1, 2026 |
| Project end | August 31, 2027 |
| Funding year | 2026 |
| Award (this year) | $319,607 |
| NIH project number | 1R43HL187080-01 |
| Project ID | NIH-11409774 on NIH RePORTER |
Who could benefit from this research
✓Could help
Adults aged 21 and older with COPD who use wearable or smartphone technology.
✕Less likely to help
Patients without access to required devices or who have conditions preventing device use may not benefit.
What this research studies
COPD flare-ups drive hospitalizations and poor outcomes. BREATHWISE will gather data from wearables and smartphones, analyze patterns with interpretable AI, and generate individualized risk notes to help patients and providers act sooner. The project aims to provide continuous monitoring, timely alerts, and practical guidance to prevent exacerbations and protect lung health. This is designed to fit into a patient’s daily routine, using noninvasive sensing and clear, actionable feedback.
Why it matters
Potential benefit: If successful, patients could experience fewer severe episodes and better quality of life through earlier intervention.
How similar studies have gone: There is prior work suggesting AI can predict COPD events, but this project emphasizes real-time multimodal sensing and interpretability.
Where this research is happening
-
Lynntech, INC.
College Station, United States Active
Researchers
- Principal investigator: Ufondu, Arinzechukwu Uchenna — Lynntech, INC.
- Study coordinator: Ufondu, Arinzechukwu Uchenna
Related research
Other NIH-funded projects on the same topics.
-
Omalizumab for COPD patients with allergen sensitization and exposure
A multicenter trial will test whether adding omalizumab helps people with COPD who are allergic to common indoor allergens and are exposed to them.
-
Clinical CT Imaging to identify and subtype pulmonary hypertension in COPD
A new CT imaging approach aims to help doctors detect and classify pulmonary hypertension in people with COPD.
-
Next-Generation Wearable AI for Precision COPD Risk and Care
A patient-centered project uses a smart wearable and AI to predict COPD flare-ups and support doctors in making better care decisions.
-
Ethics-aware Multimodal AI for COPD prevention, diagnosis, and treatment
A broad AI model uses diverse health data to help predict and manage COPD in people, with an emphasis on ethics and fairness.
-
Easier, local pulmonary rehab and social support for people with COPD in low-resource clinics
This project compares a 10-week community pulmonary rehabilitation program alone, the same program plus help with social needs, and usual care for people with moderate-to-severe COPD to see which helps people stick with rehab and feel better.
-
Improving COPD outcomes with real-world data
A doctor-scientist at a major university is using real-world information from COPD patients to understand which treatments work best, how safe they are, and whether people stick to their inhaler plans.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.